• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II SHUNT ASSEMBLY, WITH BIOGLIDE; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II SHUNT ASSEMBLY, WITH BIOGLIDE; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Catalog Number 27819
Device Problem Inaccurate Flow Rate (1249)
Patient Problem Therapeutic Response, Decreased (2271)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported to medtronic neurosurgery that the disease expected to be treated was craniocerebral trauma.According to the report, on (b)(6) 2017, the patient had right brain skull repair and left brain shunt placement.Before the surgery, the patient's lumbar puncture pressure was 300, and the implanted valve pressure was set at 2.5.After 2 days, the ventricle didn't decrease, and the physician adjusted the pressure to 2.0 on (b)(6) 2017.It was stated the ventricle still didn't reduce.On (b)(6), 2017, the physician adjusted the pressure to 1.5, but the film showed no reduction in cerebrospinal fluid.On (b)(6) 2017, the physician adjusted the pressure to 1.0 but was still ineffective.On (b)(6) the physician finally adjusted the pressure to 0.5.Reportedly, during this period, the pressure was normal.The patient's family repeatedly pressed the valve position, and the elasticity of the valve was good.The physician pressed the valve position, and the elasticity was good and both ends of the catheter were not blocked, but there was not normal drainage.The patient wasn't improving, and the doctor measured the lumbar puncture pressure to be at 400 on (b)(6) 2017.It was stated the patient had surgery to explant the terminal end of the abdominal cavity device on (b)(6) 2017.Needles did not pump out the liquid, and the patient was connected to a drainage bag and had an external drainage.After the surgery, the patient's condition improved.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The returned valve was patent.The valve met the requirements for siphon, and pre-implantation testing.However, the device did not meet the requirements for reflux and pressure-flow testing.There was proteinaceous debris observed within the interior and exterior of the valve.Debris within the valve may hold pressure-flow controlling mechanisms open resulting in fluid reflux and affecting the flow of fluid through the valve.The instructions for use (ifu) that accompany the device caution that ¿shunt obstruction may occur in any of the components of the shunt system.The system may become occluded internally due to tissue fragments, blood clots, tumor cell aggregates, bacterial colonization, or other debris.¿ the returned valve also did not meet the requirements for leak testing due to a tear observed in the top of the reservoir.It is unknown how or when this damage occurred.The ifu caution that ¿care should be taken in handling the valves as silicone has a low cut and tear resistance.¿ the ifu also caution that ¿improper use of instruments in the handling or implantation of shunt products may result in the cutting, slitting, or crushing of components.¿ a review of the manufacturing records showed no anomalies.All valves are 100% tested at the time of manufacture.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II SHUNT ASSEMBLY, WITH BIOGLIDE
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer Contact
stacy ruemping
7000 central avenue ne rcw215
minneapolis, MN 55432
7635260594
MDR Report Key6645067
MDR Text Key77704544
Report Number2021898-2017-00323
Device Sequence Number1
Product Code JXG
UDI-Device Identifier00643169010499
UDI-Public00643169010499
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K042465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/15/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Catalogue Number27819
Device Lot NumberE11602
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/17/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/06/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age45 YR
Patient Weight43
-
-